Ilaria Pazzagli, MD | Authors

BRONSON METHODIST HOSPITAL

601 JOHN ST STE M-020

Articles

Paclitaxel Plus Epirubicin in Advanced Breast Cancer

January 01, 1998

This phase I-II study aimed to determine the maximum tolerated dose (MTD) of paclitaxel (Taxol), infused over 3 hours, when combined with a fixed dose (90 mg/m²) of epirubicin. Other aims were to investigate the combination’s